Articles by Disease (Lung Cancer)

Reprograming Carcinoma Associated Fibroblasts by microRNAs

Journal: Current Molecular Medicine
Volume: 17
Page: 341-349
Author(s): Y. Xu, X. Zhou, M. Mei and Y. Ren*

Anti-Cancer Compounds Targeted to VDAC: Potential and Perspectives

Journal: Current Medicinal Chemistry
Volume: 24
Page: 4447-4469
Author(s): Simona Reina* and Vito De Pinto *

Recent Advances in Cancer Drug Development: Targeting Induced Myeloid Cell Leukemia-1 (Mcl-1) Differentiation Protein

Journal: Current Medicinal Chemistry
Volume: 24
Page: 4488-4514
Author(s): Mohammad Abid*, Yogesh A. Sonawane, Jacob I. Contreras, Sandeep Rana and Amarnath Natarajan*

First-in-human Phase 1 CRISPR Gene Editing Cancer Trials: Are We Ready?

Journal: Current Gene Therapy
Volume: 17
Page: 309-319
Author(s): Francoise Baylis* and Marcus McLeod

Natural Product Inhibitors of Topoisomerases: Review and Docking Study

Journal: Current Protein & Peptide Science
Volume: 19
Page: 275-291
Author(s): Luciana Scotti*, Francisco Jaime Bezerra Mendonca, Frederico Favaro Ribeiro, Josean Fechine Tavares, Marcelo Sobral da Silva, Jose Maria Barbosa Filho and Marcus Tullius Scotti

Antiproliferative Effects of Nerium oleander Stem and Mitotic Ar rest Induced by Cardenolide Odoroside B on NCI-H460 Cancer Cells

Journal: Letters in Drug Design & Discovery
Volume: 15
Page: 84-94
Author(s): Kehkashan Arshad Qamar*, Ahsana Dar Farooq, Bina S. Siddiqui, Nurul Kabir, Naseema Khatoon, Shakil Ahmed, Shaista Erum and Sabira Begum

Design, Synthesis and Biological Evaluation of a Novel Series of Indole-3- Carboxamide Derivatives for Cancer Treatment as EGFR Inhibitors

Journal: Letters in Drug Design & Discovery
Volume: 15
Page: 70-83
Author(s): Lan Zhang, Xin-Shan Deng, Guang-Peng Meng, Chao Zhang, Cong-Chong Liu, Gu-Zhou Chen , Xu-Liang Jiang*, Qing-Chun Zhao and Chun Hu*